Unknown

Dataset Information

Rapamycin inhibits human laryngotracheal stenosis-derived fibroblast proliferation, metabolism, and function in vitro.


ABSTRACT:

Objective

To determine if rapamycin inhibits the growth, function, and metabolism of human laryngotracheal stenosis (LTS)-derived fibroblasts.

Study design

Controlled in vitro study.

Setting

Tertiary care hospital in a research university.

Subjects and methods

Fibroblasts isolated from biopsies of 5 patients with laryngotracheal stenosis were cultured. Cell proliferation, histology, gene expression, and cellular metabolism of LTS-derived fibroblasts were assessed in 4 conditions: (1) fibroblast growth medium, (2) fibroblast growth medium with dimethylsulfoxide (DMSO), (3) fibroblast growth medium with 10(-10) M (low-dose) rapamycin dissolved in DMSO, and (4) fibroblast growth medium with 10(-9) M (high-dose) rapamycin dissolved in DMSO.

Results

The LTS f

SUBMITTER: Namba DR 

PROVIDER: S-EPMC4648293 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature